BUSINESS HOURS: Monday- Thursday 8:30am to 5pm| Friday 8:00 am to 4:00 pm

MONOCLONOAL ANTIBODY TREATMENT
BY APPOINTMENT ONLY
Learn More

TruCare Pharmacy is providing REGEN-COV Monoclonal Antibody Therapy for both treatment and prophylaxis post-exposure.
Disclaimer: There is a potential risk of treatment failure due to the development of viral variants that are resistant to REGEN-COV.
What are Monoclonal Antibodies?
Monocalonal Antibodies (mAb) are laboratory-made proteins that mimic the immune system’s ability to fight off harmful viruses. They are used to treat an existing SARS-CoV-2 infection and may help prevent progression of the disease that would otherwise require hospitalization.
mAb treatment for COVID-19 is an investigational medicine and not a substitute for getting vaccinated. The vaccine trains the body to recognize the virus to be able to fight a future infection, while mAb is used to combat a current infection. To note, protection from a COVID-19 vaccine lasts longer than treatment from mAb therapy. Where possible, it is preferable to get vaccinated rather than to contract COVID-19 and need mAb therapy.
The monoclonal antibody treatment that we provide is called REGEN-COV, which is made up of the drugs casirivimab and imdevimab. They are administered together via four subcutaneous injections. Please refer to the FDA's EUA for patients:
Who is Eligible for Monoclonal Antibody Treatment?
To be eligible, individuals must meet all of the following criteria:
-
be 12 years or older;
-
weigh at least 88 lbs;
-
be at high risk for progressing to severe COVID-19 (see high risk list below);
-
have tested positive for COVID-19 or been exposed to a positive case;
-
be within 10 days of symptom onset (ideally as soon as possible after diagnosis, even if symptoms are not too bad); AND
-
not be receiving oxygen therapy.
High risk includes any of the following:
-
65 years or older;
-
Chronic kidney disease;
-
Heart or lung disease;
-
BMI of 25 or greater;
-
Pregnancy;
-
Diabetes;
-
Sickle cell disease;
-
Neurodevelopmental disorders (for example, cerebral palsy);
-
Having a medical-related technological dependence (for example, tracheostomy, gastrostomy, or positive pressure ventilation (not related to COVID 19); OR
-
Other medical conditions or factors (for example, race or ethnicity) that may also place individual patients at high risk for progression to severe COVID-19.
REGEN-COV is not approved for use in patients who are hospitalized due to COVID-19 or who require oxygen therapy. Benefits of treatment have not been observed in patients hospitalized due to COVID-19. Monoclonal antibodies may be associated with worse clinical outcomes when given to patients with COVID-19 requiring oxygen ventilation.
If you have questions about whether mAb treatment is right for you, contact your physician or give us a call at 346-980-5828
We offer mAb treatments by appointment only. Please book below or call us at 346-980-5828